Literature DB >> 12810848

Localization of thioredoxin-interacting protein (TXNIP) mRNA in epithelium of human gastrointestinal tract.

Yasuo Takahashi1, Yukimoto Ishii, Akiko Murata, Toshihito Nagata, Satoshi Asai.   

Abstract

Thioredoxin-interacting protein (TXNIP) is a negative regulator of thioredoxin. However, its role in the gastrointestinal (GI) epithelium is as yet unknown. Using in situ hybridization, we demonstrated that mRNA of TXNIP was differentially expressed in the epithelium of the human GI tract. TXNIP transcript was especially prominent in terminal differentiated cells. TXNIP was also highly expressed in lymphocytes in the lymphoid follicles. Our results suggest a new potential role of TXNIP in the differentiation of epithelial cells and in mucosal immunity of the GI tract.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12810848     DOI: 10.1177/002215540305100713

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  3 in total

Review 1.  Thioredoxin/Txnip: redoxisome, as a redox switch for the pathogenesis of diseases.

Authors:  Eiji Yoshihara; So Masaki; Yoshiyuki Matsuo; Zhe Chen; Hai Tian; Junji Yodoi
Journal:  Front Immunol       Date:  2014-01-09       Impact factor: 7.561

2.  Thioredoxin interacting protein and its association with clinical outcome in gastro-oesophageal adenocarcinoma.

Authors:  Caroline M Woolston; Srinivasan Madhusudan; Irshad N Soomro; Dileep N Lobo; Alexander M Reece-Smith; Simon L Parsons; Stewart G Martin
Journal:  Redox Biol       Date:  2013-05-23       Impact factor: 11.799

3.  Concordance between gene expression in peripheral whole blood and colonic tissue in children with inflammatory bowel disease.

Authors:  Nathan P Palmer; Jocelyn A Silvester; Jessica J Lee; Andrew L Beam; Inbar Fried; Vladimir I Valtchinov; Fedik Rahimov; Sek Won Kong; Saum Ghodoussipour; Helen C Hood; Athos Bousvaros; Richard J Grand; Louis M Kunkel; Isaac S Kohane
Journal:  PLoS One       Date:  2019-10-16       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.